Clorox price target lowered to $145 from $150 at Citi

Citi analyst Filippo Falorni lowered the firm’s price target on Clorox to $145 from $150 and keeps a Neutral rating on the shares as part of a Q2 earnings preview for the beverage and personal care space. The firm expects another quarter with contribution from hyperinflationary pricing in emerging margins offset by currency headwinds, moderating pricing in domestic markets, with only modest improvements in volumes. Citi continues to favor names that can sustain above-peers growth, aided by emerging market exposure and lower private label penetration.